Recent Updates
-
Updated on: Dec 07, 2022
Areas That Do Not Convert from Version 4
When converting from SOAPware version 4.x to 2011/2012, all patient documents and information are carried over into the new version. However, the following areas DO NOT carry over:
Manual Clinical 2011 User Manual -
Updated on: Dec 07, 2022
Overview of Security Changes in SOAPware 2011.0
This lesson is an overview of the security changes from SOAPware 2010 to SOAPware 2011.
Manual Clinical 2011 User Manual -
Updated on: Dec 07, 2022
13. Clinical Decision Support Rule
This lesson will demonstrate the steps necessary to meet the Meaningful Use requirement for One Clinical Decision Support Rule.
Version:
SOAPware 2011 or later must be used.
Note: To determine the version of SOAPware being used, Click on Help > About SOAPware. This will open a window which will show the version and build of SOAPware currently in use.
Requirement:
Implement one clinical decision support rule and have the ability to track compliance with the rule. This will need to be an automated, electronic rule based on data elements included in the problem list, medication list, demographics, and lab test results. Notifications also need to be automatically and electronically generated to indicate real-time notifications and care suggestions based on the rule.
Measurement will be self-attestation that at least one Clinical Alert is active during the reporting period. To meet this requirement, use SOAPware's Clinical Alerts to create and track a rule.
Manual Meaningful Use Roadmap -
Updated on: Dec 07, 2022
Setting Default Font for Image Annotation
This lesson will demonstrate how to set default properties for images that are scanned or imported into SOAPware. This will work for several types of images including TIFF, JPEG, BITMAPs etc.
Note: This does not apply to PDF documents.
This setting is user-specific.
Manual Clinical 2011 User Manual -
Updated on: Dec 07, 2022
1. Record Demographics
This lesson will demonstrate the steps necessary to meet the Meaningful Use Core Measure for recording patient demographics.
Version:
SOAPware 2011 or later must be used.
Note: To determine the version of SOAPware being used, Click on Help > About SOAPware. This will open a window which will show the version and build of SOAPware currently in use.
Dashboard:
This requirement will be tracked in the MU Patient Dashboard and the Meaningful Use Dashboard.
Manual Meaningful Use Roadmap -
Updated on: Dec 07, 2022
Creating SMARText Medications
This lesson will explain how SMARText medications must be created so they are able to be ePrescribed.
Manual Clinical 2011 User Manual -
Updated on: Dec 07, 2022
Faxing and Printing from Rx Manager
This lesson will explain the steps required for setup prior to Printing or Faxing from the Rx Manager.
Manual Clinical 2011 User Manual -
Updated on: Dec 07, 2022
NQF 0073 (Additional): Ischemic Vascular Disease (IVD): Blood Pressure Management
Measure: NQF 0073 (Additional Measure)
Measure Title: Ischemic Vascular Disease (IVD): Blood Pressure Management
Measure Description: The percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous transluminal coronary angioplasty (PTCA) from January 1–November 1 of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and whose most recent blood pressure is in control (<140/90 mmHg).
*REQUIRED FOR MEANINGFUL USE (MU): Click here to view the Meaningful Use Criteria.
-
Updated on: Dec 07, 2022
NQF 0385 (Additional): Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients
Measure: NQF 0385 (Additional Measurement)
Measure Title: Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients
Measure Description: Percentage of patients aged 18 years and older with Stage IIIA through IIIC colon cancer whom are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy, or have previously received adjuvant chemotherapy within the 12-month reporting period.
-
Updated on: Dec 07, 2022
(DRAFT) NQF 0062 (Additional): Diabetes Urine Screening
THIS LESSON IS CURRENTLY A DRAFT AND IS NOT YET COMPLETE
Measure: NQF 0062 (Additional Measure)
Measure Title: Diabetes Urine Screening
Measure Description: Percentage of patients 18 - 75 years of age with Diabetes (Type 1 or Type 2) who had a nephropathy screening test or evidence of nephropathy.
*REQUIRED FOR MEANINGFUL USE (MU) ADDITIONAL MEASURE: Click here to view the Meaningful Use Criteria.